Patient Advocates Take Aim At Industry Confidentiality In Public Database
This article was originally published in The Gray Sheet
Executive Summary
A public database for device clinical trials of serious or life threatening conditions is necessary to give patients access to novel device therapies, the AIDS Project Los Angelos contends, citing the Vitrasert ganciclovir implant - developed by Chiron Vision for treatment of AIDS cytomegalovirus retinitis - as one past example.
You may also be interested in...
Voluntary Internet-Based Device Trial Clearinghouse Suggested By MDMA
Public access via the Internet to device trial information submitted voluntarily by manufacturers is adequate to direct potential subjects to clinical studies, industry reps maintain.
Public Device Trial Database Raises Confidentiality Concerns - Industry Reps
Inclusion of device clinical trial information in a mandatory, public database could stifle technological innovation in the device industry, trade association reps cautioned at a July 8 public meeting sponsored by FDA.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.